TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks

Benzinga Logo Benzinga By Vandana Singh
Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks

U.S. regulators are reviewing RSV antibody treatments after safety concerns raised by vaccine skeptics, with FDA officials initiating internal discussions about potential risks associated with infant respiratory therapies.

Insights
BHFAM   neutral

Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions


AZN   neutral

Company's RSV therapy Beyfortus is under review, but no definitive safety issues have been confirmed